Drugs / Tanshinone capsules
Tanshinone capsules
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT07123701 | Mar 2024 → Jul 2025 | COVID-19 | Liu Shuwen | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tanshinone capsules | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07123701 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “tanshinone capsules are oral traditional Chinese medicine capsules” NCT07123701 ↗ |
| Route | Oral | “orally administered” NCT07123701 ↗ |